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Mammalian STE20-like kinase MST4 regulates
multiple cellular aspects such as cell polarity and
proliferation. MST4 acts downstream of LKB1/
MO25/STRAD complex to induce brush border
formation. MO25 directly interacts with MST4 to
promote its kinase activity. Here, we report the
crystal structure of MST4 in complex with MO25.
Association of MO25 rotates the aC helix of MST4
toward its catalytic core, stabilizing the aC helix in
an active position. The kinase domain of MST4 forms
a specific homodimer that is required for trans-
autophosphorylation. MO25-stimulated activation
of MST4 promotes apoptosis in HEK293T cells.
Atomic resolution permitted the study of interface
mutations capable of disrupting the MST4-MO25
interaction or the kinase-domain-mediated homodi-
merization. These mutations impaired MST4 kinase
activation and function within the cell. Collectively,
our study identifies the activation mechanism of
MST4 and provides a structural basis for further
functional study.
INTRODUCTION
The mammalian STE20-like kinases play multiple roles in the
regulation of signaling pathways governing cell mitosis, homeo-
stasis, polarity, migration, apoptosis, proliferation, and differen-
tiation (Dan et al., 2001; Delpire, 2009; Fanger et al., 1997).
Germinal center kinases (GCKs) constitute the majority of the
STE20 family and participate in development, stress responses,
and immune regulation (Dan et al., 2001; Delpire, 2009; Ling
et al., 2008; Pombo et al., 2007; Yin et al., 2012). GCKs are
divided into eight subfamilies, and all possess a relatively con-
served N-terminal kinase domain and a diversified C-terminal
domain.
MST4 is a member of the GCK-III subfamily and is highly
expressed in placenta, thymus, and peripheral blood leukocytes
(Dan et al., 2002; Lin et al., 2001; Qian et al., 2001). The
C-terminal domain of MST4 mediates homodimerization, which
influences kinase activation (Dan et al., 2002; Qian et al.,Structure 21,2001). MST4a, an alternatively spliced isoform lacking
substrate-binding subdomains, is specifically expressed during
early stages of development (Qian et al., 2001).
MST4 may activate the extracellular signal-regulated kinase
(ERK) signaling pathway to regulate cell growth and transforma-
tion (Lin et al., 2001). Overexpression of MST4 in prostate
cancer cell lines increases cell proliferation and contributes to
anchorage-independent growth (Sung et al., 2003). During this
process, MST4 may be activated by epidermal growth factor
(EGF) and function downstream of the EGF receptor (EGFR)
family. However, other studies, done with different cell lines,
showed that MST4 might not readily activate ERK, p38, JNK,
and NF-kB pathways (Qian et al., 2001).
The scaffold protein MO25 binds to the pseudokinase STE20-
related adaptor (STRAD) and liver kinase B1 (LKB1) to form
a ternary complex, which is critical for the activation of LKB1
(Boudeau et al., 2003; Zeqiraj et al., 2009a). LKB1 induces
complete polarization of intestinal epithelial cells, which allows
the regulated uptake of nutrients (Baas et al., 2004). During this
process, MST4 acts downstream of LKB1 to phosphorylate the
actin-binding protein Ezrin and induce brush border formation
(ten Klooster et al., 2009). Recently, the small G protein Rap2A
was identified as a molecular link directly coupling microvilli
formation to the preceding cell polarization (Gloerich et al.,
2012). LKB1 triggered apicobasal polarity creates a microenvi-
ronment for Rap2A signaling through its downstream effector
TRAF2 and NCK-interacting protein kinase (TNIK), which, in
turn, targets MST4 for apical recruitment. The brush border
formation is therefore controlled by Rap2A and TNIK through
apical localization of MST4 followed by phosphorylation of Ezrin.
In addition to activating LKB1, MO25 can directly interact with
certain STE20 kinases including MST4, MST3, STK25, oxidative
stress-responsive 1 protein (OSR1), and STE20/SPS1-related
proline-alanine-rich protein kinase (SPAK) and dramatically
increase their kinase activities (Filippi et al., 2011). The structure
of MO25 in complex with the pseudokinase STRAD was previ-
ously resolved, revealing an active conformation of STRAD
(Zeqiraj et al., 2009b). The concave surface of MO25 forms an
extensive interaction network with STRAD. The 3-amino-acid
(Trp-Glu-Phe, WEF) motif C-terminal to the kinase domain of
STRAD, which is essential for MO25 binding, is embedded into
a hydrophobic pocket of the horseshoe shapedMO25 (Boudeau
et al., 2003; Milburn et al., 2004). Based on the conserved motif
analysis, it was proposed that MST4 would bind to MO25 in
a similar manner as does STRAD (Filippi et al., 2011). However,449–461, March 5, 2013 ª2013 Elsevier Ltd All rights reserved 449
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Structure of MST4-MO25 Complexit is unclear whether this is the case, and, if so, how MO25
regulates the activation and function of MST4 remains largely
unknown.
Here, we report the crystal structure of MST4 kinase domain
in complex with MO25. The MST4 kinase domain N-lobe, aE
helix of C-lobe, and the conserved Trp-Ser-Phe (WSF) motif
interact intensively with MO25 in a similar manner observed in
STRAD-MO25 complex (Filippi et al., 2011; Zeqiraj et al.,
2009b). Importantly, MO25 binding rotates the aC helix of
MST4 to a closed active conformation, promoting the kinase
activity of MST4. Moreover, in the presence of MO25, the kinase
domain of MST4 forms a homodimer that differs from the
previously reported dimer of apo MST4. Structure-guided
biochemical and cell-based studies support and further corrob-
orate the mechanistic model of MST4 activation in which MST4
is regulated by MO25 binding and homodimerization of kinase
domain.
RESULTS
Reconstitution of the MST4-MO25 Complex
MST4 comprises a kinase domain (amino acids 1–297), a linker
region (amino acids 298–346) with a MO25-binding motif (WSF
in MST4; WEF in STRAD), and a C-terminal dimerization domain
(amino acids 347–416) (Figure 1A) (Ceccarelli et al., 2011; Record
et al., 2010). MO25 is composed of seven a-helical repeats
(designated as R0–R6) (Milburn et al., 2004). Previous work has
demonstrated that MST4 is a MO25-regulated kinase (Filippi
et al., 2011; ten Klooster et al., 2009). To confirm the biological
existence of a stable MST4-MO25 complex in vivo and in vitro,
we first transfected HEK293T cells with constructs encoding
cyan fluorescent protein (CFP)-tagged MO25 or/and YFP-
tagged MST4 to check the cellular localization of MO25 and
MST4 (Figure 1B). Consistent with previous notion that MO25
diffused freely between cytoplasm and nucleus (Boudeau
et al., 2003), we found that MO25 was widely distributed
throughout the cell when overexpressed alone. On the other
hand, MST4 was predominantly localized in cytoplasm and
could hardly be detected in nucleus. Strikingly, MO25 was
dramatically excluded from nucleus and retained in cytoplasm
when cotransfected with MST4, a phenomenon also observed
when MO25 was cotransfected with STRAD (Boudeau et al.,
2003). Overall, these observations suggested that MST4 and
MO25 are colocalized in cells and their association prevents
MO25 from shuttling between cytoplasm and nucleus by free
diffusion.
We then performed coimmunoprecipitation (co-IP) by trans-
fecting HEK293T cells with constructs expressing Myc-tagged
MO25 and different fragments of Flag-tagged MST4 including
full-length MST4 (amino acids 1–416), C-terminal truncation
MST4 (amino acids 1–327), and MST4 (amino acids 1–297), as
well as a kinase dead mutation MST4 D162A (amino acids 1–
416). Flag-tagged MST4 was immunoprecipitated and then
precipitates were immunoblotted with anti-Flag and anti-Myc
antibody (Figure 1C). Myc-taggedMO25 was detected in the im-
munoprecipates of all MST4 fragments. Together with the coloc-
alization analysis, these results clearly indicated that MST4 and
MO25 coexist in a complex in cells, possibly through MST4
kinase domain.450 Structure 21, 449–461, March 5, 2013 ª2013 Elsevier Ltd All righNext, we used purified recombinant proteins to detect the
direct interactions between MO25 and different MST4 frag-
ments using Octet Red 96 (ForteBio). Compared with full-length
MST4, the fragment 18–327 had similar binding affinity to
MO25, yet the fragment 18–297 showed apparently reduced
level of MO25 binding (Table 1; Figure S1 available online).
This observation indicated that the MST4 linker region contain-
ing the MO25-binding motif (WSF motif) might enhance its
interaction with MO25, although MST4 kinase domain alone
could form complex with MO25. It has been reported that
ATP could promote STRAD binding to MO25 (Zeqiraj et al.,
2009b). We then tested whether the binding of MST4 and
MO25 was influenced by the presence of ATP. Our results
showed that ATP did not seem to affect MST4 binding to
MO25 (Table 1; Figure S1). The binding affinity of MST4 for
MO25 is higher than that of STRAD in the absence of ATP,
while similar binding affinities for MO25 were observed when
ATP is present (Figure S1).
It was previously shown that MO25 promotes MST4 kinase
activity towardmyelin basic protein (MBP), a general kinase sub-
strate (Filippi et al., 2011). We performed in vitro kinase assays
using purified proteins of full-length MST4 and various frag-
ments. As shown in Figure 1D, full-length MST4 and truncation
fragments 18–327 or 18–297 had similar kinase activities. Addi-
tion of MO25 increased MST4 kinase activity by approximately
10-fold. As a negative control, the kinase dead mutant of
MST4 (D162A) did not show significant activity alone or in the
presence of MO25 (Figure 1D).
Structure of MST4-MO25 Complex
After the confirmation of the stable MST4-MO25 complex and
the characterization of the minimum domains required for
complex assembly, we purified MST4 kinase domain (amino
acids 18–297, D162A) in complex with MO25 (amino acids 11–
334) and crystallized the complexwith or without a cyclin-depen-
dent kinase 1/2 (CDK1/2) inhibitor III (DKI) and a peptide
‘‘EWSFT’’ which mimics the MO25-binding motif (Figures S2A–
S2C). The crystal of MST4-MO25 complex diffracted to 3.15 A˚
resolution. Structures were determined by molecular replace-
ment with final Rwork of 0.206 and Rfree of 0.252. The refinement
statistics were summarized in Table 2.
The overall structures of MST4-MO25 complex with inhibitor
compound DKI or WSF motif peptide are very much the same
to that of the MST4-MO25 complex alone (Figure 2A). The asym-
metric unit of the MST4-MO25 crystals contains one molecule of
MST4 and one molecule of MO25 bound to each other, forming
a 1:1 subcomplex. Further examination of symmetry-related
molecules indicated that MST4 and MO25 form a 2:2 tetrameric
heterocomplex on the basis of MST4-kinase-domain-mediated
homodimer, consistent with in vitro kinase assays (see more
details below). No significant conformational change was
observed for MO25. The rmsd value is 1.35 A˚ on 311 Ca atoms
when the complexed-MO25 structure overlapped with the apo
MO25 structure reported previously (Milburn et al., 2004). In
brief, MO25 is composed of seven a-helical repeats and forms
a horseshoe shape. The concave surface of MO25 interacts
with the N-lobe and the aE helix of MST4 kinase domain. The
monomer structure of the MST4 kinase domain observed in
MST4-MO25 complex crystals is similar to the MST4 kinasets reserved
Figure 1. MO25 Binds to MST4 and Stimulates Its Kinase Activity
(A) Schematic illustration of domain organization for human MST4 and MO25. MST4 contains a kinase domain at the N terminus, following with a linker
region, which contains a Trp-Ser-Phe (WSF) motif, and a dimerization domain at the C terminus. MO25 is composed of seven a-helical repeats (designated as
R0-R6).
(B) The CFP-tagged MO25 and YFP-tagged MST4 were transfected alone or cotransfected into HEK293T cells, and proteins were visualized by confocal
microscopy.
(C) The indicated constructs of Myc-tagged MO25 and Flag-tagged MST4 were cotransfected into HEK293T cells. Cells were lysed, and Flag-taggedMST4 was
immunoprecipitated (IP) with anti-Flag antibody and subjected to immunoblot (IB) analysis. The relative association was calculated by ratio of Myc-tagged and
Flag-tagged protein level in IB and the association between MST4 (amino acids 1–416) and MO25 was set to 1.0. b-actin was used as an independent loading
control.
(D) The different MST4 fragments were assayed for determining the ability of MST4 to phosphorylate myelin basic protein (MBP) in the absence or presence of
MO25. Error bars represent SD of data obtained in three independent experiments.
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Structure of MST4-MO25 Complexdomain structure determined alone with the exception of a repo-
sitioned aC helix and a well defined activation loop (A-loop) (Fig-
ure S3) (Record et al., 2010). The rmsd of overlapping these two
MST4 structures is 1.84 A˚ for the complete kinase domain (amino
acids 18–297), and 1.41 A˚ when the aC helix and A-loop were
excluded. Notably, the ordered A-loop of MST4 in our complex
structures adopted an inactive conformation that would block
substrate binding.Structure 21,A DKI compound was found in the ATP binding pocket of
MST4 in the MST4-MO25-DKI complex (Figure 2A), consistent
with previous finding that DKI binds to MST4 with high affinity
(Record et al., 2010). The glycine-rich loop and the region
between b4 and aD of MST4 tether the DKI molecule to the
hydrophobic active cleft between the two lobes of the kinase
domain (Figure S3). Similar as observed for the quinazoline inhib-
itor compound GVD bound to MST4, residues L102 and D109 of449–461, March 5, 2013 ª2013 Elsevier Ltd All rights reserved 451
Table 1. MST4 Directly Interacts with MO25 In Vitro through
N-Terminal Region
Analyte KD1 (nM) KD2 (nM)
MST4 9.12 80.0
MST4 (18–326) 9.18 281
MST4 (18–297) 99.1 69.5
MST4 + ATP 10.8 118
Binding of MO25 to various MST4 fragments was determined by Octet
Red 96 using purified recombinant proteins. Various fragments of
biotinylated-MST4 were immobilized on streptavidin (SA) biosensors
and incubated with varying concentrations of MO25 protein. Association
(kon) and dissociation (koff) rates were measured and calculated
using Octet Data Analysis Software 7.0. KD values were calculated as
KD = kon/koff. See also Figure S1.
Table 2. Data Collection and Refinement Statistics
MST4-MO25
MST4-MO25-
WSF
MST4-MO25-
DKI
Data Collection
Space group I432 I432 I432
Cell dimensions
a, b, c (A˚) 237.6, 237.6,
237.6
239.3, 239.3,
239.3
239.5, 239.5,
239.5
a, b, g () 90, 90, 90 90, 90, 90 90, 90, 90
Resolution (A˚) 50.0–3.15
(3.20–3.15)a
50.0–3.25
(3.31–3.25)
50.0–3.65
(3.71–3.65)
Rmerge 0.138 (0.906) 0.099 (0.816) 0.189 (0.815)
I / sI 28.0 (4.0) 23.0 (2.9) 19.1 (4.1)
Completeness (%) 99.9 (100.0) 99.6 (99.8) 99.6 (100.0)
Redundancy 20.8 (19.9) 6.8 (6.5) 12.8 (13.6)
Refinement
No. reflections 18,854 17,610 12,643
Rwork / Rfree 0.206/0.252 0.220/0.260 0.252/0.309
No. atoms
Protein 4,870 4,589 4,859
Ligand/ion 18 6 28
Water 12 3 0
Rmsds
Bond lengths (A˚) 0.008 0.007 0.007
Bond angles () 1.305 1.133 1.323
aValues in parentheses are for highest-resolution shell.
Structure
Structure of MST4-MO25 ComplexMST4 directly interacted with the oxygen atom and the amino
group of DKI by hydrogen bonding.
Details of the MST4-MO25 Interaction
Previous studies identified fourmajor sites (termed A, B, C, andD
sites) on STRAD for the binding of MO25, three of which interact
with the concave surface of MO25 (Filippi et al., 2011; Zeqiraj
et al., 2009b). Correspondingly, MST4 mainly interacts with the
MO25 concave surface through three major sites involving the
MST4 kinase domain N-lobe and the aE helix (Figure 2A). For
site A, the loop between the b3 sheet and the aC helix of
MST4 kinase domain forms intensive interactions with the H3
helix of the MO25 repeat R4 and R5 (termed R4H3 and R5H3,
similarly naming hereinafter). This binding network involves
residues Y223, R227, K231, S267, and N269 of MO25 and
E58, E61, and E63 from the aC helix region of MST4, which
form hydrogen bonding and electrostatic interactions, contrib-
uting a total of 222 A˚2 buried surface area (Figure 2B). In addition,
the aC helix of MST4 walks along the concave surface of MO25,
burying a total of 354 A˚2 surface area (Figure 2C). Particularly
residues E65 and Q68 in the aC helix of MST4 interact with
S182 and Q228 from the H3 helix of the MO25 repeat R3 and
R4 by electrostatic interactions.
For site B, residue F178 in the H3 helix of the MO25 repeat R3
extends to a hydrophobic region of MST4, involving residues L57
near the b3 sheet, L90 in the b4 sheet, L95 in the b5 sheet, and
V224 in the H3 helix of the MO25 repeat R4. The buried surface
area of the hydrophobic region is up to 275 A˚2 (Figure 2D). More-
over, residue D179 in the H3 helix of the MO25 repeat R3 inter-
acts with residues Y85 and S88 from the MST4 b4 sheet through
hydrogen bonding.
At C site, the aE helix from the C-lobe of MST4 kinase domain
interacts with the H3 helix of the MO25 repeat R1 (Figure 2E).
Specifically, residues E93 and K96 of MO25 interacted with
Y134 and E138 of MST4. These interactions were mainly medi-
ated by hydrogen bonding and salt bridges.
For the relatively isolated site D, the WSF motif of MST4 binds
intimately to the hydrophobic pocket on the C-terminal convex
surface of MO25 (Figure 2F). Hydrophobic packing mediated
by the WSF motif appears dominant in this site. For example,
the side chains of W324 and F326 of the WSF motif form hydro-
phobic interactions with residues K257, M260, L263, F278, I294,
K301, L302, and F305 of MO25, burying a total of 424 A˚2 molec-452 Structure 21, 449–461, March 5, 2013 ª2013 Elsevier Ltd All righular surface. In addition, K297, N298, and K301 of MO25 form
hydrogen bonds with S325 and the main chain of the motif.
Moreover, a pair of cation-p interaction was observed between
W324 of the WSF motif and R264 of MO25, highlighting W324
as a critical residue for interaction with MO25. All the key resi-
dues in the interface of MST4 and MO25 are highly conserved
between different species, indicating a conserved role of
MO25 for regulating MST4 (Figures S4A and S4B).
MST4 Kinase Activity Is Regulated by MO25 Binding
After the examination of the MST4-MO25 interface, we per-
formed biochemical- and cellular-based assays to verify our
crystallographic analysis and identify specific amino acids
most critical for MST4-MO25 association. To this end, a series
of mutants based on the full-length MST4 and MO25 were con-
structed. Purified recombinant proteins were then used to detect
interactions between wild-type or mutant of MST4 and MO25 by
Octet Red 96. Circular dichroism (CD) spectroscopy results
showed that the overall structures and folds of these mutant
proteins have not been altered when compared with wild-type
MST4 or MO25 (Figure S5). Single mutations F178E (site B),
Y223A, R227A (site A), M260E (site D) and double mutation
F178E/V224E (site B) of MO25 greatly impaired its interaction
with MST4 (Table 3; Figure S6). Similarly, single mutations
L95E (site B), Y134A (site C), W324E (site D), and double muta-
tion L90E/L95E (site B) of MST4 markedly reduced its associa-
tion with MO25. Single mutation E138A (site C) of MST4 did
not significantly affect their association. Furthermore, co-IPts reserved
Figure 2. Interface of MST4 and MO25 Complex
(A) Overall structure and interface of MST4 and MO25 complex. MST4 is shown in cartoon representation and colored yellow, and MO25 is shown in cartoon
representation and colored green. The WSF motif is colored red and the inhibitor compound DKI is shown as stick and colored magenta. MST4 has four
conserved sites for MO25 binding, termed sites A, B, C, and D, respectively.
(B) Detailed view of site A. The aC helix of MST4 interacts with helices Helix 3 of Repeat 3 (R3H3), R4H3, and R5H3 in the concave surface of MO25 via hydrogen
bonding and electrostatic interactions.
(C) Representative experimental electron density map at 3.15 A˚ resolution contoured at 1.0 s. The aC helix of MST4 and part of MO25 are shown.
(D) Detailed view of site B. The b4 and b5 sheets of MST4 and helices R3H3 and R4H3 of MO25 form a hydrophobic core. Hydrogen bonds are also involved
in this site.
(E) Detailed view of site C. The aE helix of MST4 interacts with R1H3 helix of MO25 via hydrogen bonding and electrostatic interactions.
(F) Detailed view of site D. The WSF motif of MST4 binds to a hydrophobic pocket in the C-terminal convex surface of MO25.
The magenta dashes represent hydrogen bonding or electrostatic interactions. Single-letter abbreviations for the amino acid residues are as follows: A, Ala;
C, Cys; D, Asp; E, Glu; F, Phe; G, Gly; H, His; I, Ile; K, Lys; L, Leu; M, Met; N, Asn; P, Pro; Q, Gln; R, Arg; S, Ser; T, Thr; V, Val; W, Trp; and Y, Tyr.
See also Figures S2–S4.
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Structure of MST4-MO25 Complexwas performed to analyze these interactions in cells (Figures 3A
and 3B). Mutations F178E, Y223A, R227A, M260E, and F178E/
V224E of MO25 and E58A (site A), L95E, Y134A, W324E, and
L90/L95E of MST4 impaired MO25 association with MST4,
consistent with Octet results. Collectively, these observations
suggest that all four sites are required for MST4 interaction
with MO25; i.e., disruption any of these sites would block
complex formation.
To further analyze the mechanism of MST4 activation stimu-
lated by MO25 binding, we used purified recombinant proteins
to measure the kinase activity of MST4 toward MBP in the pres-
ence or absence of MO25 (Figures 3C and 3D). Our results
showed that wild-type MO25 promoted the kinase activity of
wild-type MST4 dramatically. However, the MO25 mutants
(F178E, Y223A, R227A, M260E, and F178E/V224E) and MST4
mutants (E58A, W324E, E58A/E61A, and E63A/E65A) that im-
paired MST4-MO25 interactions as shown by Octet and co-IP
could not activate MST4 kinase as did wild-type proteins, corre-Structure 21,lating MO25 binding to the regulation of MST4 kinase activity.
Moreover, these MST4 mutants (except Y134A) retained a basal
level of kinase activity similar to that of wild-type MST4 in the
absence of MO25, corroborating the folding integrity of MST4
mutant proteins. These results further confirmed the necessity
of all four sites for complex formation and MST4 activation.
It is interesting that Y134A mutant of MST4 showed no kinase
activity regardless of MO25 binding (Figure 3D). We checked the
structure of MST4 and found that the residue Y134 lies under the
aChelix and forms hydrogen bond and salt bridges with residues
Q76, C77, and D78 near the aC helix (Figure S7). Thus, Y134A
mutant abolished MST4 activity probably through alteration of
the aC helix conformation.
Kinase-Domain-Mediated Homodimerization
Is Required for MST4 Activation
In the crystals of MST4-MO25 complex, the MST4 kinase
domain can form homodimer in two different manners (referred449–461, March 5, 2013 ª2013 Elsevier Ltd All rights reserved 453
Table 3. Mutational Analysis of MST4-MO25 Interface
Analyte
KD1
(nM)
KD2
(nM) Analyte
KD1
(nM)
KD2
(nM)
MO25 (WT) 9.12 80.0 MST4 (WT) 9.12 80.0
MO25 (F178E) 22.8 39.7 MST4 (L95E) ND ND
MO25 (Y223A) 77.9 24.2 MST4 (Y134A) ND ND
MO25 (R227A) 51.7 22.0 MST4 (E138A) 18.7 35.6
MO25 (M260E) ND ND MST4 (W324E) ND 109
MO25 (F178E/V224E) ND ND MST4 (L90E/L95E) ND ND
Binding affinities between MST4 and MO25 were determined by Octet
Red 96 using purified wild-type and mutant proteins. Wild-type or mutant
biotinylated-MST4 were immobilized on SA biosensors and incubated
with varying concentrations of wild-type or mutant MO25 proteins. Asso-
ciation (kon) and dissociation (koff) rates were measured and calculated
using Octet Data Analysis Software 7.0. KD values were calculated as
KD = kon/koff. ND, not determined. See also Figures S5 and S6.
Structure
Structure of MST4-MO25 Complexto as type A and type B, respectively). For type A dimer, the A-
loop and the following aEF and aG helices form a symmetric
interface with a nature of hydrophobic interactions (Figure 4A).
Residues M186 in the A-loop, V190, and I191 in the aEF helix
and M225, L228, and F229 in the aG helix form a hydrophobic
core, while residues D171 and K233 form salt bridges
surrounding the dimeric core for additional stabilization. The total
buried accessible surface for this type of dimerization is 822 A˚2.
Alternatively, the aE helix and the aH, aJ and aK helices of MST4
mediate type B dimerization (Figure 4B). In this case, two
aromatic residues (F119) in the aE helix of two MST4 molecules
pack against each other. Residues D242 and T244 near the aH
helix, K276 in the aJ helix, and Y283 and E286 in the aK helix
of one MST4 molecule form hydrogen bonding and electrostatic
interactions with the same group of residues of other molecule. A
total of 422 A˚2 surface area is buried in this type of dimerization.
As crystal packing may cause artifacts, we carried out co-IP
and in vitro kinase assays to verify our crystallographic observa-
tion regarding the MST4-kinase-domain-mediated dimerization.
The C-terminal region of MST4 is known to mediate homodime-
rization. To assess the kinase-domain-mediated dimerization
without interference by the C-terminal dimerization domain, we
used the N-terminal fragment of MST4 containing the kinase
domain with WSF motif (amino acids 1–327) to perform co-IP
assay in HEK293 cells. According to different types of dimeriza-
tion, two groups of mutations based on the N-terminal fragment
of MST4 were designed to probe MST4 homodimerization
through kinase domain. The first group of mutations derived
from type A dimeric interface, including mutations M225E,
L228E and F229A, and deletion of residues 222–233 (del 222–
233), impaired homoassociation of the MST4 kinase domain as
shown by co-IP in HEK293T cells (Figures 5A). Moreover, this
group of mutations abolished the kinase activity of MST4 no
matter MO25 is present or not (Figure 5B). On the contrary,
the second group of mutations derived from type B dimeric
interface (mutations F119E and D242A/K276A) only partly
reduced homoassociation of the MST4 kinase domain and
slightly decreased its kinase activity (Figures 5A and 5B). To
rule out the possibility that mutation alters overall structural
folding of MST4 and therefore affect its dimerization, we used
CD spectroscopy to monitor secondary structures of these454 Structure 21, 449–461, March 5, 2013 ª2013 Elsevier Ltd All righmutant proteins (Figure S5). The CD results suggested that no
major change of overall folding occur upon introduction of muta-
tions. Additionally, we tested the interactions between wild-type
MO25 and different MST4 mutants. The Octet results indicated
that the binding affinity decreased, especially for those muta-
tions in type A dimerization interface (Figure S8). We speculate
that this could be caused by decreased avidity due to disruption
of MST4 dimer, as well as perturbed conformation of the activa-
tion loop that is adjacent to the MO25 binding interface. Taken
together, these observations indicated that type A but not type
B dimerization is of physiological relevance, and that the
kinase-domain-mediated homoassociation of MST4 is a prereq-
uisite for its autophosphorylation, activation, and further stimula-
tion by MO25.
MO25-Stimulated Activation of MST4 Promotes
Apoptosis
To gain further functional insights into theMST4-MO25 complex,
we overexpressed wild-type and mutant MST4 in HEK293T
cells. Propidium iodide staining showed that transfection of
either wild-typeMST4 orMO25 significantly promoted apoptosis
(Figure 6A). More strikingly, coexpression of wild-typeMST4 and
MO25 resulted in dramatically increased apoptosis. Similarly,
coexpression of wild-type MO25 with MST4 E138A mutant,
which partially impaired kinase activation stimulated by MO25,
also enhanced apoptosis, although to a lesser extent. However,
coexpression of wild-type MO25 and MST4 mutants W324E or
E58A/E61A that disrupted MST4-MO25 association did not
induce substantial apoptosis, indicating a critical role of MO25
association induced MST4 activation. Moreover, coexpression
of a kinase dead version of MST4 (D162A) with wild-type
MO25 did not cause apoptosis, suggesting that MST4 kinase
activity is essential for MST4 and/or MO25 induced apoptosis.
Finally, we further confirmed these observations by TUNEL
assay. As shown in Figure 6B, coexpression of MO25 with
wild-type or mutant MST4 promoted apoptosis in a similar trend
as observed by fluorescence-activated cell sorting.
DISCUSSION
Comparison of MST4-MO25 with STRAD-MO25
The overall structure of the MST4-MO25 complex is similar to
that of the pseudokinase STRAD in complex with MO25
(Figure 7A), consistent with previous studies (Filippi et al.,
2011; Zeqiraj et al., 2009b). The interaction between MST4 and
MO25 is mediated by several conserved sites identified from
the STRAD-MO25 complex interface. Mutation or deletion of
the WEF motif of STRAD abolished its binding with MO25 (Bou-
deau et al., 2003). Our crystallographic study, Octet analysis,
in vitro kinase assays and co-IP results indicate that removal of
theWSFmotif (site D) by truncation reduces but does not disrupt
MST4-MO25 complex formation. However, mutation of this
site in the context of full-length MST4 significantly limited its
interaction with MO25, suggesting that the WSF-motif-mediated
interaction stabilizes a needed conformation of MST4 when it
associates with MO25 in cells.
When associated withMO25, STRAD adopts an active confor-
mation and as such its A-loop is extended to ‘‘touch’’ the R0 and
R1 helical repeats from the concave side of MO25. However, ints reserved
Figure 3. MST4 Kinase Activity Regulated
by MO25
(A) The indicated constructs of Flag-tagged wild-
type MST4 and Myc-tagged wild-type or mutant
MO25 were cotransfected into HEK293T cells.
Cells were lysed, and Flag-tagged MST4 was
immunoprecipitated with anti-Flag antibody and
subjected to immunoblot (IB) analysis. The relative
association was calculated by ratio of Myc-tagged
and Flag-tagged protein level in IB and the asso-
ciation between wild-type MST4 and MO25 was
set to 1.0. b-actin was used as an independent
loading control.
(B) The indicated constructs of Myc-tagged wild-
type MO25 and Flag-tagged wild-type or mutant
MST4 were cotransfected into HEK293T cells.
Cells were lysed, and Myc-tagged MO25 was
immunoprecipitated with anti-Myc antibody and
subjected to IB analysis. The relative association
was calculated by ratio of Flag-tagged and Myc-
tagged protein level in IB and the association
between wild-type MO25 and MST4 was set
to 1.0.
(C and D) In vitro kinase assay of MST4 using MBP
as substrate. The purified wild-type MST4 protein
was mixed with various purified MO25 mutant
proteins for detection of kinase activity (C). The
purified wild-type MO25 protein was mixed with
various purified MST4 mutant proteins for detec-
tion of kinase activities (D). The wild-type and
mutant MST4 proteins in the absence of MO25
were used for detection of basal level of kinase
activity. Error bars represent SD of data obtained
in three independent experiments.
See also Figures S5 and S7.
Structure
Structure of MST4-MO25 Complexour structure of the MST4-MO25 complex, MST4 appears to be
in a transition state between the ‘‘inactive’’ and fully ‘‘active’’
states. A feature of the MST4 transition state is that its aC helix
is in a closed conformation while its A-loop is folded back to
the substrate cleft. Based on comparison of MST4-MO25 and
STRAD-MO25 complexes, we propose that upon activation,
the loop between the R0 and R1 helices of MO25 shifts toward
MST4. Together with R0 and R1 repeats, this rearranged loop
of MO25 can interact with the autophosphorylated A-loop of
MST4 to stabilize an extended active conformation (see more
below).
Conformational Change of MST4 aC Helix Induced
by MO25 Binding
When compared with the structure of theMST4 kinase domain in
apo state (Record et al., 2010), the aC helix of MST4 in complex
state is rotated by MO25 toward its catalytic core (Figure 7B).Structure 21, 449–461, March 5, 2013This conformational change of aC helix
resulted in an 8 A˚ shortening of the
distance between the K53 residue of the
conserved Val-Ala-Ile-Lys (VAIK) motif
and the E70 residue of the aC helix,
promoting formation of a canonical ion
pair, which keeps the MST4 kinase
domain in a closed conformation. Thiseffect renders the aC helix of MST4 in a position that is observed
in active conformations of kinases such asMST3 (Ko et al., 2010)
and STK25 (Protein Data Bank [PDB] ID: 2XIK). The distance of
the K53-E70 pair is reduced from 11.9 A˚ (apo MST4, inactive
state) to 3.1 A˚ (MST4-MO25 complex), which is even shorter
than those ofMST3 (4.0 A˚) and STK25 (4.2 A˚) in their active states
(Figure 7B).
Together with our mutational studies, these observations
suggested that the conformational change of the aC helix is a
hallmark of the mechanisms through which MO25 stimulates
MST4 activation. This principle has been observed for other
kinases such as cyclin-dependent kinase 2 (CDK2) (Honda
et al., 2005; Jeffrey et al., 1995). Cyclin A or cyclin E binds to
the C helix of CDK2, resulting in a rotation of the C helix (i.e.,
the PSTAIRE helix, similar to aC helix) and subsequent formation
of K33-E51 ion pair which keeps CDK2 in an active conforma-
tion. Moreover, the binding mode between MST4 and MO25ª2013 Elsevier Ltd All rights reserved 455
Figure 4. MST4 Kinase Domain Forms Sym-
metric Homodimers in Crystal Structure
(A) Type A dimerization interface of MST4 kinase
domain. The two molecules of MST4 are colored
yellow and orange, respectively. The activation
loop (A-loop) and the following aEF and aG helices
form a symmetric dimer through hydrophobic
interactions.
(B) Type B dimerization interface of MST4 kinase
domain. The colors are the same as type A
dimerization. The aE, aH, aJ, and aK helices of
MST4 are involved in this dimerization.
Structure
Structure of MST4-MO25 Complexalso resembled the interactions between CDK2 and cyclin A/E.
Notably, the hydrophobic cleft nearby the C helix of CDK is
also involved in the association with cyclin A/E. Other examples
include cyclic-AMP-dependent protein kinase (PKA) and Aurora
A/B kinases. The C-terminal hydrophobic motif of PKA binds to
its kinase domain N-lobe and activates PKA (Knighton et al.,
1991). Aurora A/B can be activated by binding of a hydrophobic
motif in targeting protein for Xklp2 (TPX2)/inner centromere
protein (INCENP) (Bayliss et al., 2003; Sessa et al., 2005). These
shared features reflect a universal activation mechanism in
which a hydrophobic area of a regulatory partner or a hydro-
phobic motif of a subunit or domain binds to the hydrophobic
cleft nearby the aC helix of the kinase domain to induce a closed
conformation.
Kinase-Domain-Mediated Homodimerization Is
Required for MST4 trans-Autophosphorylation
Previous structural study of the MST4 kinase domain alone also
revealed a dimeric association involving the A-loop (Record
et al., 2010). Our current work revealed a 2:2 MST4-MO25
complex with homodimerization of the MST4 kinase domain
involving the aEF/aG helices and the A-loop. Structural compar-
ison of the MST4 kinase domain homodimer identified in this
study and the previously reported one reveal conformational
rearrangements of the dimer from the apo state to the MO25-
complexed state (Figures 7C, 7D, and S9A–9C). It is likely that
MO25 binding alters the conformation of the MST4 kinase
domain by rotating the aC helix, which then induces reorganiza-
tion of the dimeric interface for activation. Our co-IP and in vitro
kinase assay showed that mutations disrupting the dimeric
interface of MST4 abolished its kinase activity, highlighting the
functional importance of the particular dimeric conformation
identified in the structure of MST4 in complex with MO25
(Figure 5).
Single mutation such asM225E or L228E that disrupt the type-
A homodimerization of the MST4 kinase domain completely456 Structure 21, 449–461, March 5, 2013 ª2013 Elsevier Ltd All rights reservedabolished MST4 kinase activity, even
though the rest of the catalytic elements
including the aC helix, A-loop, active
cleft, and the substrate binding motif
were intact. However, mutations disrupt-
ing type-B homodimer of MST4 did not
significantly affect its kinase activity.
These observations strongly indicate
that it is the type A dimeric conformationof the kinase domain, per se, is required for the activation
of MST4.
In the presence of MO25, the MST4 kinase domain forms
a dimer via the aEF/aG helices and the A-loop. A-loop exchange
of kinases has recently been discussed as a mechanism for
trans-autophosphorylation (Lee et al., 2009; Pike et al., 2008;
Villa et al., 2008). For example, the A-loop and aEF, aF, and
aG helices are involved in dimerization in certain kinases
including STE20-like serine/threonine-protein kinase (SLK),
lymphocyte-oriented kinase (LOK), OSR1, and death-associated
protein kinase 3 (DAPK3). In our structure, in addition to the
A-loop, the homodimerization interface of MST4 also includes
the Ala-Pro-Glu (APE) motif and P+1 loop, which are related
to substrate binding, suggesting that one MST4 molecule
may serve as a substrate of another. Therefore, dimerization
of the MST4 kinase domain is required for its trans-
autophosphorylation.
Functional Implications of the MST4-MO25 Complex
MST4 has been implicated in the regulation of cell polarity and
growth control (Dan et al., 2002; Lin et al., 2001; Ma et al.,
2007; Sung et al., 2003; ten Klooster et al., 2009). In fact, the
other two GCK-III subfamily members MST3 and STK25, which
are highly homologous with MST4, are also involved in cas-
pase-dependent or independent apoptosis (Chen et al., 2009;
Huang et al., 2002; Lin et al., 2010; Nogueira et al., 2008; Wu
et al., 2008, 2011).
Our cell-based assays indicated that MST4 and MO25 asso-
ciate together to promote apoptosis in HEK293T cells. These
studies corroborated the structural and biochemical studies of
the MST4-MO25 complex. We found that neither MST4 kinase
dead mutant (D162A) nor MST4 mutations (W324E and E58A/
E61A) that disrupt its interaction with MO25 could efficiently pro-
mote apoptosis. Our results suggest that these MST4 mutants
play a dominant-negative role by forming homodimers with
endogenous MST4 and therefore preventing efficient MO25
Figure 5. MST4 Kinase Activity Regulated
by Homodimerization
(A) Wild-type HA-tagged MST4 (amino acids 1–
327) and the indicated constructs of Flag-tagged
MST4 (amino acids 1–327) were cotransfected into
HEK293T cells. Cells were lysed, and Flag-tagged
MST4 (amino acids 1–327) was immunoprecipi-
tated (IP) with anti-Flag and subjected to immu-
noblot (IB) analysis. The relative association was
calculated by ratio of HA-tagged and Flag-tagged
protein level in IB and the association between
wild-type HA-tagged MST4 (amino acids 1–327)
and Flag-tagged MST4 (amino acids 1–327) was
set to 1.0. b-actin was used as an independent
loading control.
(B) In vitro kinase assay of MST4 using MBP as
substrate. The kinase activities of purified wild-
type and mutant MST4 proteins were detected in
the absence or presence of purified wild-type
MO25. Error bars represent SD of data obtained in
three independent experiments.
See also Figure S5 and S8.
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Structure of MST4-MO25 Complexstimulation on MST4. Taken together, our observations suggest
that MO25-stimulated activation of MST4 promotes apoptosis,
but further studies are required to identify and dissect molecular
signaling pathways by which MST4 induces apoptosis.
Conclusions
The actions of most kinases are regulated by different mecha-
nisms involving phosphorylation, dimerization, subdomain and
subunit interactions, and coregulator binding. Our study iden-
tifies a working model for MO25 stimulated MST4 activation, in
which binding of MO25 poses two major conformational effects
on MST4. The first is to promote a closed conformation of the
active site by rotating the aC helix inward and formation of the
conserved K53-E70 ion pair; the second is to induce specific
homodimerization of the kinase domain, which is required
for trans-autophosphorylation of MST4 (Figure 7E). After trans-
autophosphorylation, conformational change of A-loop destabi-
lizes the kinase domain-mediated MST4 homodimer, allowing
substrate binding. This model is also applicable for the activationStructure 21, 449–461, March 5, 2013of other MO25-stimulated STE20 kinases
such as MST3 and STK25.
EXPERIMENTAL PROCEDURES
Cloning, Protein Expression, and
Purification
Human MST4 (amino acids 18–297, D162A) and
MO25 (amino acids 11–334) were cloned into
vector HT-pET-28a and expressed in E. coli
BL21(DE3) cells. MST4 and MO25 were purified
by Ni affinity chromatography and size exclusive
chromatography. Purified proteins of MO25 and
MST4weremixedwith equimolar ratio and applied
to HiLoad 16/60 Superdex 200 again.
Crystallization, Structure Determination,
and Refinement
The protein of MST4-MO25 complex was concen-
trated to 10 mg/ml. When performing crystalscreen experiment, we added different kinase inhibitors such as DKI, stauro-
sporine, purvalanol B, GSK-3 inhibitor XIII, ATP analogs such as adenosine
50-(b,g-imido) triphosphate (ANP), adenosine 50-(g-thio) triphosphate (AGS)
and MO25-binding peptide (EWSFT) to the protein for crystallization purpose.
Crystals were grown in reservoir solution consisted of 0.1 M Tris (pH 8.0),
18%–20% polyethylene glycol 350 monomethyl ether. Diffraction data were
collected at beamline BL17U, Shanghai Synchrotron Radiation Facility
(SSRF) of China, and processed using HKL2000 (Otwinowski and Minor,
1997). The structure of MST4-MO25 complex was resolved by molecular
replacement.
Interaction Analysis Using Octet Red 96
Interaction analysis was performed using an Octet Red 96 instrument (Forte-
Bio) (Ekiert et al., 2011). Wild-type or mutant MST4 was labeled by biotin in
20 mM HEPES (pH 7.5), 100 mM NaCl, 1 mM DTT, and biotinylated proteins
were immobilized on streptavidin (SA) biosensors and incubated with varying
concentrations of MO25 in 13 kinetics buffer. Data were analyzed using Octet
Data Analysis Software 7.0 (ForteBio).
Confocal Microscopy
HEK293T cells were transfected with indicated constructs encoding CFP-
tagged MO25 or/and YFP-tagged MST4. Cells were stained for the nucleusª2013 Elsevier Ltd All rights reserved 457
Figure 6. MO25-Stimulated Activation of MST4 Promotes Apoptosis
(A) HEK293T cells were transfected with the indicated constructs encoding Myc-tagged MO25 and/or Flag-tagged MST4. Cells were stained with PI
and analyzed by flow cytometer. The apoptosis fraction is indicated by purple line. The numbers are the percentage of apoptosis corresponding to each
sample.
(B) HEK293T cells were transfected with the indicated constructs encoding Myc-tagged MO25 and/or Flag-tagged MST4. Apoptosis was determined by TUNEL
assay using an in situ cell death detection kit. Cells were fixed and assayed for TUNEL activity (green), a measure of caspase-dependent DNA fragmentation
typically produced in apoptotic cells. Nuclei were stained red by PI.
Structure
Structure of MST4-MO25 Complexusing 10 mg/ml DAPI in PBS and prepared for confocal analysis (Leica
LAS SP5).
Immunoprecipitation
HEK293T cells were transiently transfected with constructs encoding Myc-
tagged MO25 or/and Flag-tagged MST4. Cells were lysed and the superna-
tants were incubated with anti-Myc or anti-Flag antibody and protein A/G
agarose antibody (Santa Cruz). The immune complexes were subjected to
SDS-PAGE, and analyzed by western blot.
In Vitro Kinase Assay
The activity of recombinant MST4 and its mutants were assayed by using
myelin basic protein (MBP) as substrate. One unit (U) of protein kinase activity458 Structure 21, 449–461, March 5, 2013 ª2013 Elsevier Ltd All righis that amount that catalyzes the incorporation of 1 nmol phosphate into MBP
in 1 min (Hastie et al., 2006).
Flow Cytometry
HEK293T cells were transfected with constructs encoding Myc-tagged MO25
or/and Flag-tagged MST4. The cells were incubated with 50 mg/ml propidium
iodide (PI) in PBS with 0.2 mg/ml RNase A and 0.1% Triton X-100, and
analyzed by flow cytometer.
TUNEL Assay
HEK293T cells were transfected with constructs encoding Myc-tagged MO25
or/and Flag-tagged MST4. Apoptosis was determined by TUNEL assay using
an in situ cell death detection kit (Roche Applied Science).ts reserved
Figure 7. Structural Features of MST4 Activation
(A) Structural comparison ofMST4-MO25with STRAD-MO25. TheMO25molecule in these two complexes was used for superimposition. The overall structure of
MST4-MO25 complex is similar to that of STRAD-MO25 complex (PDB ID: 3GNI). MST4 is colored yellow, and STRAD colored slate. MO25 is colored green.
(B) Structural comparison of MST4 in MO25-complexed state (yellow) with apo MST3 (cyan, PDB ID: 3A7G) and STK25 (purple, PDB ID: 2XIK) kinases in their
active states, and apo MST4 (light blue, PDB ID: 3GGF) in its inactive state. MO25 binding rotates MST4 aC helix toward catalytic center, promoting an active
conformation of the aC helix. During this process, the distance between the conserved key residues K53 and E70 (numbered in MST4) was decreased from 11.9
to 3.1 A˚, resulting in ion pair interaction.
(C and D) Structural comparison of MST4 homodimerization in MO25-complexed state and apo state. The conformations of MST4 homodimer in MO25-
complexed state (yellow and orange) (C) and apo state (light blue and wheat) (PDB ID: 3GGF) (D) are distinct. However, the A-loop and following aEF and aG
helices are involved in MST4 homodimerization in both states.
(E) A schematic model for MO25 regulated MST4 activation. MO25 activates MST4 by rotating the aC helix to a closed active conformation and modulating the
specific dimerization mode that is required for trans-autophosphorylation. After trans-autophosphorylation, conformational change of A-loop destabilizes the
kinase domain-mediated MST4 homodimer, allowing substrate binding.
See also Figure S9.
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